Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Signaling

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. STKE, 16 October 2001
Vol. 2001, Issue 104, p. tw377
[DOI: 10.1126/stke.2001.104.tw377]

EDITORS' CHOICE

KINASE INHIBITION Regulating Protein Kinase B

Abstract: Protein kinase B (PKB) has proven to be a key regulatory element in growth factor signaling, cell survival, and transformation to a cancerous phenotype. Maira et al. screened for proteins that physically interacted with PKB and identified a human protein, which they call carboxyl-terminal modulator protein (CTMP), that binds to PKB at the plasma membrane and inhibits activation of the kinase. Inhibition of CTMP expression enhanced activation of PKB, whereas cells expressing a viral homolog of PKB became transformed and proliferated abnormally and could form tumors in vivo. However, clones of such cells stably expressing CTMP grew more slowly and either failed to form tumors in vivo or formed tumors that grew more slowly. Thus, CTMP appears to be an important regulator of PKB, an enzyme with critical roles from insulin signaling to protection of cells from apoptosis.

S.-M. Maira, I. Galetic, D. P. Brazil, S. Kaech, E. Ingley, M. Thelen, B. A. Hemmings, Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science 294 374-380 (2001). [Abstract] [Full Text]

Citation: Regulating Protein Kinase B. Sci. STKE 2001, tw377 (2001).

ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (pre-2008: Science's STKE. ISSN 1525-8882)